Spot Outliers Like ResMed Early with Money Flows

RMD designs, manufactures, and distributes respiratory equipment for sleep-related and other respiratory disorders. As for earnings, RMD is due to report again on July 31, but its third-quarter fiscal 2025 report showed $1.3 billion in revenue (an 8% gain), a 14% jump in operating profit, and $579 million of operating cash generated.

It’s no wonder RMD shares are up 21% so far this year – and they could rise more. MoneyFlows data shows how Big Money investors are again betting heavily on the stock.

Big Money Flows to ResMed

Institutional volumes reveal plenty. In the last year, RMD has enjoyed strong investor demand, which we believe to be institutional support.

Each green bar signals unusually large volumes in RMD shares. They reflect our proprietary inflow signal, pushing the stock higher:

Plenty of health care names are under accumulation right now. But there’s a powerful fundamental story happening with ResMed.

ResMed Fundamental Analysis

Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, RMD has had strong sales and earnings growth:

• 3-year sales growth rate (+13.6%)
• 3-year EPS growth rate (+30.5%)

Source: FactSet

Also, EPS is estimated to ramp higher this year by +11.8%.

Now it makes sense why the stock has been generating Big Money interest. RMD has a track record of strong financial performance.

Marrying great fundamentals with MoneyFlows software has found some big winning stocks over the long term.

ResMed has been a top-rated stock at MoneyFlows for years. That means the stock has unusual buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

It’s garnered 82 outlier inflow signals since 2000 and is up 3,142% since its first appearance on the rare Outlier 20 report…Big Money loves it:

Tracking unusual volumes reveals the power of money flows.

This is a trait that most outlier stocks exhibit…the best of the best. Big Money demand drives stocks upward.

ResMed Price Prediction

The RMD action isn’t new at all. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

Disclosure: the author owns RMD in personal and managed accounts at the time of publication.

If you are a Registered Investment Advisor (RIA) or are a serious investor, take your investing to the next level and follow our free weekly MoneyFlows insights.